The Tirzepatide Weight Loss Program is a clinician-guided telehealth program built around compounded tirzepatide, a dual-action medication that works on two metabolic pathways (GIP and GLP-1) to reduce appetite, quiet food noise, and support blood sugar balance
This recommendation is real, meaningful progress toward a regulated market where patients can trust what they're putting in their bodies from reputable U.S
By Julian Gill June 23, 2026 The high price tag for FDA-approved GLP-1s sends more patients to compounding pharmacies, taking Empowers sales to a new level
Regulatory Considerations TB500 is not approved for human use by regulatory agencies in many countries, presenting legal and quality control challenges
When GLP-1 spending spikes by hundreds of millions of dollars, that cost does not disappear
Placental therapy: An insight to their biological and therapeutic properties